Literature DB >> 14628858

Neurobehavioural deficits following postnatal iron overload: II Instrumental learning performance.

T Archer, N Schröder, A Fredriksson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14628858     DOI: 10.1007/BF03033374

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.978


× No keyword cloud information.
  89 in total

Review 1.  Iron in brain function and dysfunction with emphasis on Parkinson's disease.

Authors:  M B Youdim; D Ben-Shachar; P Riederer
Journal:  Eur Neurol       Date:  1991       Impact factor: 1.710

2.  Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity.

Authors:  S Przedborski; V Kostic; V Jackson-Lewis; A B Naini; S Simonetti; S Fahn; E Carlson; C J Epstein; J L Cadet
Journal:  J Neurosci       Date:  1992-05       Impact factor: 6.167

3.  Increased iron in the substantia nigra of 6-OHDA induced parkinsonian rats: a nuclear microscopy study.

Authors:  Y He; P S Thong; T Lee; S K Leong; C Y Shi; P T Wong; S Y Yuan; F Watt
Journal:  Brain Res       Date:  1996-09-30       Impact factor: 3.252

Review 4.  Behavioural pharmacology of glutamate receptors in the basal ganglia.

Authors:  W J Schmidt; B D Kretschmer
Journal:  Neurosci Biobehav Rev       Date:  1997-07       Impact factor: 8.989

Review 5.  Oxidants, antioxidants, and the degenerative diseases of aging.

Authors:  B N Ames; M K Shigenaga; T M Hagen
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

6.  Superoxide dismutase: correlation with life-span and specific metabolic rate in primate species.

Authors:  J M Tolmasoff; T Ono; R G Cutler
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

7.  6-Hydroxydopamine releases iron from ferritin and promotes ferritin-dependent lipid peroxidation.

Authors:  H P Monteiro; C C Winterbourn
Journal:  Biochem Pharmacol       Date:  1989-12-01       Impact factor: 5.858

8.  Aceruloplasminemia: molecular characterization of this disorder of iron metabolism.

Authors:  Z L Harris; Y Takahashi; H Miyajima; M Serizawa; R T MacGillivray; J D Gitlin
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

9.  Neurobehavioral dysfunctions associated with dietary iron overload.

Authors:  T J Sobotka; P Whittaker; J M Sobotka; R E Brodie; D Y Quander; M Robl; M Bryant; C N Barton
Journal:  Physiol Behav       Date:  1996-02

10.  Parkinson plus syndrome: diagnosis using high field MR imaging of brain iron.

Authors:  B P Drayer; W Olanow; P Burger; G A Johnson; R Herfkens; S Riederer
Journal:  Radiology       Date:  1986-05       Impact factor: 11.105

View more
  7 in total

1.  Postnatal iron-induced motor behaviour alterations following chronic neuroleptic administration in mice.

Authors:  A Fredriksson; P Eriksson; T Archer
Journal:  J Neural Transm (Vienna)       Date:  2005-08-05       Impact factor: 3.575

2.  Development of neurological reflexes and motor coordination in rats neonatally treated with monosodium glutamate.

Authors:  P Kiss; A Tamas; A Lubics; M Szalai; L Szalontay; I Lengvari; D Reglodi
Journal:  Neurotox Res       Date:  2005-11       Impact factor: 3.911

3.  Functional consequences of iron overload in catecholaminergic interactions: the Youdim factor.

Authors:  Trevor Archer; Anders Fredriksson
Journal:  Neurochem Res       Date:  2007-08-12       Impact factor: 3.996

4.  Subchronic administration of haloperidol influences the functional deficits of postnatal iron administration in mice.

Authors:  A Fredriksson; T Archer
Journal:  Neurotox Res       Date:  2006-10       Impact factor: 3.911

5.  Subchronic administration of haloperidol influences the functional deficits of postnatal iron administration in mice.

Authors:  Anders Fredriksson; Trevor Archer
Journal:  Neurotox Res       Date:  2006-06       Impact factor: 3.911

6.  Changes in open-field activity and novelty-seeking behavior in periadolescent rats neonatally treated with monosodium glutamate.

Authors:  P Kiss; D Hauser; A Tamás; A Lubics; B Rácz; Z S Horvath; J Farkas; F Zimmermann; A Stepien; I Lengvari; D Reglódi
Journal:  Neurotox Res       Date:  2007-09       Impact factor: 3.911

Review 7.  Brain sites of movement disorder: genetic and environmental agents in neurodevelopmental perturbations.

Authors:  T Palomo; R J Beninger; R M Kostrzewa; T Archer
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.978

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.